Optimal oncologic management and mTOR inhibitor...

International Journal of Cancer 2018 / 08

Optimal oncologic management and mTOR inhibitor introduction are safe and improve survival in kidney and liver allograft recipients with de novo carcinoma

Rousseau, B., Guillemin, A., Duvoux, C., Neuzillet, C., Tlemsani, C., Compagnon, P., Azoulay, D., Salloum, C., Laurent, A., de la Taille, A., Salomon, L., Cholley, I., Haioun, C., Dupuis, J., Wolkenst
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
International Journal of Cancer
DOI:
10.1002/ijc.31769
Date:
August, 2018
File:
PDF, 3.41 MB
english, 2018
Conversion to is in progress
Conversion to is failed